Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

02/08/2019 08:00

Aug 2 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.11               15.26            65.00    
                 (-1.0 pct)          (-4.5 pct)       (+5.1 pct)  
  Operating          1.33                1.63             5.00    
                 (-18.6 pct)        (+173.5 pct)      (+33.8 pct) 
  Recurring          1.56                1.74             5.00    
                 (-10.6 pct)        (+162.4 pct)      (+51.7 pct) 
  Net                1.15                2.24             3.80    
                 (-48.9 pct)        (+241.3 pct)      (+10.0 pct) 
  EPS             24.14 yen           44.59 yen        80.75 yen  
  Ann Div                             34.00 yen        34.00 yen  
  -Q2 div                             17.00 yen        17.00 yen  
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T